About Company
- Legal Name: CRODA
- International Name: Croda International Plc
- Brand / Trade Name: Croda Pharma
- Registered country: China
- Address: China Mainland Shanghai Shanghai Room 701-703, Block C, Oriental Guoxin Business Plaza, No. 388 Fuquan North Road, Changning District, Shanghai
- Established year: 1925
Description:
Founded in the UK in 1925, Croda is a globally established supplier of high-purity pharmaceutical excipients, vaccine adjuvants, and novel liposomes to leading pharmaceutical companies, universities, and research institutes, operating across small-molecule delivery, protein delivery, vaccine nucleic acid delivery, and vaccine adjuvant technology platforms. Its portfolio includes the Super Refined Polysorbate and Poloxamer 188 excipient lines, the PHAD synthetic MPLA and other vaccine adjuvants developed over more than 80 years, and the Avanti Lipids range of GMP-grade lipids, which supplied key lipid nanoparticle excipients for Pfizer's first COVID-19 mRNA vaccine in 2020. Manufacturing bio products and pharmaceutical excipients and selling worldwide, Croda combines its China operations (based in Shanghai) with global reach, and is recognized for its brand, international certifications, experienced R&D personnel, production capacity, rich product line, and high-quality service.
Business Activities
Drug Delivery Systems
SupplierManufacturer
Excipients & Additives
Excipient SupplierManufacturer
Contract & Outsourcing Services
CDMO / CMO
Biopharmaceutical Products
Our Products & Services
Sell · Excipients & Additives
Sell · Excipients & Additives
Sell · Excipients & Additives
Certifications
GMP
GMP-grade lipid portfolio includes DSPC
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment